On Friday, November 12, 2021, Sentara Hospital System in Virginia submitted a motion to dismiss the complaint filed against it earlier in the week by Dr. Paul Marik—co-chief medical officer of the FLCCC, tenured professor, and the Director of the Intensive Care Unit at Sentara Norfolk General Hospital. Dr. Marik filed suit seeking a temporary injunction to lift the ban Sentara Healthcare System had placed on a range of highly effective COVID-19 treatments used by Dr. Marik to save critically ill COVID-19 patients. These components, including IV vitamin C, dutasteride, fluvoxamine, finasteride, and ivermectin, had previously been successfully used—with the exception of ivermectin, the use of which Sentara never permitted
Hospital Files Motion to Dismiss Dr. Paul…
On Friday, November 12, 2021, Sentara Hospital System in Virginia submitted a motion to dismiss the complaint filed against it earlier in the week by Dr. Paul Marik—co-chief medical officer of the FLCCC, tenured professor, and the Director of the Intensive Care Unit at Sentara Norfolk General Hospital. Dr. Marik filed suit seeking a temporary injunction to lift the ban Sentara Healthcare System had placed on a range of highly effective COVID-19 treatments used by Dr. Marik to save critically ill COVID-19 patients. These components, including IV vitamin C, dutasteride, fluvoxamine, finasteride, and ivermectin, had previously been successfully used—with the exception of ivermectin, the use of which Sentara never permitted
Create your profile
Only paid subscribers can comment on this post
Check your email
For your security, we need to re-authenticate you.
Click the link we sent to , or click here to sign in.